I'm an associate editor at ACG Case Reports Journal. I read case reports every week. Most get rejected for the same 3 fixable reasons. Submitting to #ACG2026? Read this first 🧵
Dr Allison Schulman presents compelling keynote address on the emerging role of endoscopy in metabolic disease! 🙌 ESG now has a CPT code @allie_schulman @umichmed @JessWidmer3@MarkPochapin
Dreams can come true.
>10 years of research, friendship, and team building with patients and caregivers brought us to these beautiful results.
Together we (@serperm) prevented falls in patients with cirrhosis.
journals.lww.com/hep/abstrac…
Dreams can come true.
>10 years of research, friendship, and team building with patients and caregivers brought us to these beautiful results.
Together we (@serperm) prevented falls in patients with cirrhosis.
journals.lww.com/hep/abstrac…
We prevented falls that resulted in fractures, head injury, brain bleeding. And we did it with a low dose of a generic medication with or without remote “TeleTai-Chi”.
journals.lww.com/hep/abstrac…
We - Marina Serper Donna and Sumeet - are proud to publish our trial in @HEP_Journaljournals.lww.com/hep/abstrac…
With gratitude to our patient partners, the patient participants, and the team of coordinators that made this work happen
It is hard to replace the 1:1 RCT
There was - is there still? - enthusiasm for micro randomization & SMART in clinical research.
1. These designs get problematic if your proposed trial has a longer duration (at risk for censoring), especially if enrolling sick patients
2. Power calculations are generally done based on the first randomization especially in cost-constrained environments
3. Conclusions involving the later randomizations are often murky and very difficult to communicate
1/ It's #MalnutritionAwarenessWeek. Malnutrition is common in cirrhosis, and we've known it for decades. What we haven't done is build it into routine care the way we did carvedilol and pHTN. We need to routinely screen for it and proactively manage it when present.
The updated impact factor for @HepCommJournal is now 6.2, up 35% from the prior year
On the clinical side we have had the same crew of AEs from the start. Neehar, @IanARowe, @DoctorSharad, @BloomPringle, and @DrLChina
This year Lok went to hepatology and we welcomed @ponnivp